| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.00▼ | 1.00▼ | 0.99▲ | 0.98▲ | 0.93▲ |
| MA10 | 0.99▲ | 0.99▲ | 0.98▲ | 0.98▲ | 0.96▲ |
| MA20 | 0.98▲ | 0.98▲ | 0.98▲ | 0.92▲ | 1.11▼ |
| MA50 | 0.99▲ | 0.97▲ | 0.98▲ | 0.96▲ | 1.13▼ |
| MA100 | 0.98▲ | 0.94▲ | 0.93▲ | 1.14▼ | 1.28▼ |
| MA200 | 0.94▲ | 0.96▲ | 0.96▲ | 1.11▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.002▲ | 0.001▲ | 0.011▲ | -0.013▼ |
| RSI | 52.230▲ | 53.106▲ | 53.628▲ | 53.640▲ | 45.864▼ |
| STOCH | 78.704 | 83.148▲ | 67.204 | 57.877 | 40.956 |
| WILL %R | -33.333 | -33.333 | -33.333 | -17.266▲ | -67.987 |
| CCI | 39.675 | 46.049 | 58.990 | 49.752 | -19.526 |
|
Tuesday, April 29, 2025 05:30 AM
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared ...
|
|
Tuesday, April 29, 2025 01:39 AM
MOUNTAIN VIEW, Calif. - RenovoRx, Inc. (NASDAQ: RNXT), a biopharmaceutical company specializing in targeted cancer therapies with a market capitalization of $35.5 million, has announced the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 0.99 | 1.005 | 0.97 | 0.9901 | 112,645 |
| 30/04/25 | 0.97 | 0.985 | 0.95 | 0.96 | 71,100 |
| 29/04/25 | 0.98 | 0.99 | 0.973 | 0.973 | 36,075 |
| 28/04/25 | 0.98 | 1.04 | 0.97 | 0.972 | 33,978 |
| 25/04/25 | 0.9508 | 1.01 | 0.95 | 0.99 | 69,383 |
| 24/04/25 | 0.98 | 1.01 | 0.95 | 1.01 | 200,200 |
| 23/04/25 | 0.95 | 0.9952 | 0.9401 | 0.98 | 171,257 |
| 22/04/25 | 0.94 | 1.00 | 0.94 | 0.95 | 43,300 |
| 21/04/25 | 1.01 | 1.02 | 0.94 | 0.95 | 37,200 |
| 17/04/25 | 1.03 | 1.04 | 0.98 | 1.02 | 109,206 |
|
|
||||
|
|
||||
|
|